Inspire Corporate Bond ETF (IBD) is a publicly traded the market company. As of May 21, 2026, IBD trades at $23.80 with a market cap of $0 and a P/E ratio of 0.00. IBD moved +0.00% today. Year to date, IBD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Inspire 500 ETF Hits $679.5M AUM with 30.55% Two-Year Return: Inspire 500 ETF amassed $679.5 million in assets under management by March 25, 2026, marking significant growth since its March 2024 launch. The ETF delivered a 30.55% total return over two years versus the S&P 500’s 29.95%, with a 0.09% expense ratio.
| Metric | Value |
|---|---|
| Price | $23.80 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 139.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
IBD analyst coverage data. Average price target: $0.00.